These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28754585)

  • 1. The Impact of the American College of Obstetricians and Gynecologists Guideline Changes in Pap Tests on Annual Chlamydia Test Rates.
    Hsieh HL; Huppert J; Patel CG; Tao G
    J Adolesc Health; 2017 Oct; 61(4):440-445. PubMed ID: 28754585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Significant Decreases Over Time in the Proportion of Sexually Active Medicaid Women Who Had Papanicolaou Testing or Were Pregnant on Trends of Overall Chlamydia Testing Rates.
    Tao G; Kreisel K; Gift TL
    Sex Transm Dis; 2018 Nov; 45(11):e90-e93. PubMed ID: 30044337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding sexual activity defined in the HEDIS measure of screening young women for Chlamydia trachomatis.
    Tao G; Walsh CM; Anderson LA; Irwin KL
    Jt Comm J Qual Improv; 2002 Aug; 28(8):435-40. PubMed ID: 12182161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2009 cervical cytology guidelines and chlamydia testing among sexually active young women.
    Tao G; Hoover KW; Kent CK
    Obstet Gynecol; 2010 Dec; 116(6):1319-1323. PubMed ID: 21099597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confusion regarding cervical cancer screening and chlamydia screening among sexually active young women.
    Ogbechie OA; Hacker MR; Dodge LE; Patil MM; Ricciotti HA
    Sex Transm Infect; 2012 Feb; 88(1):35-7. PubMed ID: 22123163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Changes in Cervical Cancer Screening Guidelines on Chlamydia Testing.
    Naimer MS; Kwong JC; Bhatia D; Moineddin R; Whelan M; Campitelli MA; Macdonald L; Lofters A; Tuite A; Bogler T; Permaul JA; McIsaac WJ
    Ann Fam Med; 2017 Jul; 15(4):329-334. PubMed ID: 28694268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Massachusetts HMOs in providing Pap smear and sexually transmitted disease screening to adolescent females.
    Thrall JS; McCloskey L; Spivak H; Ettner SL; Tighe JE; Emans SJ
    J Adolesc Health; 1998 Mar; 22(3):184-9. PubMed ID: 9502004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding sexual activity and Chlamydia testing rate based on linked national survey and Medicaid claims data.
    Tao G; Hua J; Chen JL
    PLoS One; 2015; 10(4):e0122927. PubMed ID: 25875858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia screening among sexually active young female enrollees of health plans--United States, 2000-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(14):362-5. PubMed ID: 19373196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Chlamydia Screening Rate in Young Sexually Active Women Using HEDIS Measures in the United States, 2011 to 2020.
    He L; Patel C; Tao G
    Sex Transm Dis; 2023 Jul; 50(7):415-419. PubMed ID: 36943794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Cervical Cancer Screening Guidelines on Screening for Chlamydia.
    Ursu A; Sen A; Ruffin M
    Ann Fam Med; 2015; 13(4):361-3. PubMed ID: 26195682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia testing patterns for commercially insured women, 2008.
    Tao G; Hoover KW; Kent CK
    Am J Prev Med; 2012 Apr; 42(4):337-41. PubMed ID: 22424245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing for Chlamydia and sexual history taking in adolescent females: results from a statewide survey of Colorado primary care providers.
    Torkko KC; Gershman K; Crane LA; Hamman R; Barón A
    Pediatrics; 2000 Sep; 106(3):E32. PubMed ID: 10969116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating Chlamydia screening rates by using reported sexually transmitted disease tests for sexually active women aged 16 to 25 years in the United States.
    Tao G; Tian LH; Peterman TA
    Sex Transm Dis; 2007 Mar; 34(3):180-2. PubMed ID: 16865052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of data collection for the HEDIS performance measure on chlamydia screening in an MCO.
    Wei F; Walsh CM
    Am J Manag Care; 2003 Sep; 9(9):585-93. PubMed ID: 14527104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for chlamydia in adolescents and young women.
    Mangione-Smith R; McGlynn EA; Hiatt L
    Arch Pediatr Adolesc Med; 2000 Nov; 154(11):1108-13. PubMed ID: 11074851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of strategies to increase chlamydia screening in young women.
    Scholes D; Grothaus L; McClure J; Reid R; Fishman P; Sisk C; Lindenbaum JE; Green B; Grafton J; Thompson RS
    Prev Med; 2006 Oct; 43(4):343-50. PubMed ID: 16782182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State Variation in Enrollment Gap, Sexual Activity, and Chlamydia Testing Rate Among Young Medicaid Women.
    Tao G; Patel CG
    Sex Transm Dis; 2016 Oct; 43(10):595-8. PubMed ID: 27626186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Potentially Unnecessary Bimanual Pelvic Examinations and Papanicolaou Tests Among Adolescent Girls and Young Women Aged 15-20 Years in the United States.
    Qin J; Saraiya M; Martinez G; Sawaya GF
    JAMA Intern Med; 2020 Feb; 180(2):274-280. PubMed ID: 31904768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of regular chlamydia testing by U.S. women: a longitudinal study.
    Heijne JC; Tao G; Kent CK; Low N
    Am J Prev Med; 2010 Sep; 39(3):243-50. PubMed ID: 20709256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.